1. Chinese expert panel in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Chinese Expert Consensus on the Diagnosis and Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(AECOPD)(2017 Update). Int J Respir. 2017;37(14):1041–1057. doi:10.3760/cma.j.issn.1673-436X.2017.14.001
2. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
3. Writing Group of Expert Consensus on Anti-infective Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Expert consensus on anti-infective therapy for acute exacerbation of chronic obstructive pulmonary disease in China. Int J Respir. 2019;39(17):1281–1296.
4. GOLD.Global Strategy for the Diagnosis, Management, and Preventi on of Chronic Obstructive Pulmonary Disease[EB/OL]. Available from: https://goldcopd.org/2021-gold-reports/. Accessed September 15, 2022.
5. Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study